The current and future management of acute heart failure syndromes. - Wikidata - wikimedia - TriplyDB

The current and future management of acute heart failure syndromes.

The current and future management of acute heart failure syndromes.

http://www.wikidata.org/entity/Q37703984

about

Ivabradine as adjuvant treatment for chronic heart failure Nitrates for acute heart failure syndromes Ivabradine as adjuvant treatment for chronic heart failure Nutritional Deficiency in Patients with Heart Failure Global changes in the rat heart proteome induced by prolonged morphine treatment and withdrawal Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study.Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure Rapid evaluation by lung-cardiac-inferior vena cava (LCI) integrated ultrasound for differentiating heart failure from pulmonary disease as the cause of acute dyspnea in the emergency setting Evaluation of a provocative dyspnea severity score in acute heart failure.Heart failure in South America.Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure Tolvaptan for the treatment of heart failure: a review of the literature.Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes.Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC.Critical reappraisal of pulmonary artery catheterization and invasive hemodynamic assessment in acute heart failure.Treatment of acute heart failure in the emergency department.Vasopressin receptor antagonists: from pivotal trials to current practice.Hyperglycemia in acute heart failure: an opportunity to intervene?The role of intravenous vasodilators in acute heart failure management.Copeptin as a biomarker in heart failure.Editor's Choice- Call to action: Initiation of multidisciplinary care for acute heart failure begins in the Emergency Department.Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).Creation and validation of the acute heart failure risk score: AHFRS.Prognostic Value of Urinary Neutrophil Gelatinase-Associated Lipocalin on the First Day of Admission for Adverse Events in Patients With Acute Decompensated Heart Failure.Spinal Neuronal NOS Signaling Contributes to Morphine Cardioprotection in Ischemia Reperfusion Injury in Rats.Unmasking the truth.A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry.Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).Clinical profiles in acute heart failure: one size fits all or not at all?Increasing self-knowledge: Utilizing tele-coaching for patients with congestive heart failure.Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes.Clinical trials in acute heart failure: beginning of the end or end of the beginning?[Treatment of acute heart failure].Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction†A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial

P2860

Q24185982-3E54AFFA-6292-4AFC-9B3D-5BAA6A146FAC Q24200550-12A2F5C0-8D9E-4762-82DE-2635718DDAE8 Q24201614-C055A552-C5EF-484C-8578-8F1A9E3A7D76 Q26741764-AA0D8200-E9FD-485B-BDA0-A798BF45DDA6 Q28484293-26AD09B0-B753-4376-9EB7-D513EADDDD93 Q30446792-EC43AAF0-486A-4489-AFFE-466BDD51370F Q34492056-9DD89766-1C08-4DC7-BD1F-3B9932181AA9 Q35114953-21D06B5D-5747-4A1B-9CAD-445703CA357C Q36480294-8FB5307F-4BE0-42F4-9640-8DC17D13F241 Q36564895-D485661B-3132-46CC-8CDB-158F7EF04B5F Q36928523-1D5D56D9-2601-45B3-8C09-E8E098C332B9 Q37457781-89EF3BB0-89F7-4064-94CC-A42A56FE616C Q37852720-938E038D-2575-4171-AE92-885BEA69D6ED Q37889518-0FD891C8-6F3E-4B8D-8AD0-8AFD4974B336 Q37895014-272B46FE-1F13-46AF-A546-75D8B947DF69 Q38097505-80912998-DB1F-4EEF-8163-5B31008C51C7 Q38145265-EF2D70B0-66AE-43B1-983A-B7CE5A877808 Q38160378-797B0E68-AADF-456B-BEC6-88F0CF7872A4 Q38217112-365EC8CC-C489-4B30-8704-914089012887 Q38237577-3BBC9729-C40E-4E12-A8D0-B81F3DD37623 Q38249996-FDAB4D38-FC9D-4E3E-A4ED-28DF9CB9BEA6 Q38437103-EFC78891-C68C-40BF-82E4-D47BFD479137 Q38689033-954B5776-8281-4036-AF62-B8CBC100FE3B Q39300538-FAFFC895-B590-47B5-8133-F03AAF403CFA Q41104212-AA1CD394-E33D-4011-A680-669018866204 Q41150348-C6898AD7-92B9-4D29-B02E-710AB03C93F9 Q41984203-BEAA8DE2-7C6B-4282-9998-80A34132FC4A Q43479728-3824595D-A17B-4D99-9425-5BAF3BAAD427 Q43534981-A790CE29-DA9A-4DC6-8658-6DE9ACC25E8E Q47195489-855BFCAE-A4FF-4EED-B348-F6EA6F7E00B3 Q50201301-294A00CB-60E7-4D1D-8183-DED268E70A09 Q51373718-451141FB-8319-4D2A-ADD9-284EB33082D3 Q53192175-15E482FB-3286-4937-BED4-185058B649D2 Q53603789-82FE8748-C664-4297-A11B-6E344C123F4B Q57628656-5193B8CC-DDCD-40CA-A886-B068EE1345E6 Q57628767-5552DC0C-1D79-4E79-9624-D69FD0095370

P2860

The current and future management of acute heart failure syndromes.

http://www.wikidata.org/entity/Q37703984

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The current and future management of acute heart failure syndromes.

@en

The current and future management of acute heart failure syndromes.

@nl

type

label

The current and future management of acute heart failure syndromes.

@en

The current and future management of acute heart failure syndromes.

@nl

prefLabel

The current and future management of acute heart failure syndromes.

@en

The current and future management of acute heart failure syndromes.

@nl

P1433

Q37703984-0C31AB57-55EA-4CF5-9BDA-5F1CC4B83D9E

P1476

Q37703984-9E88F9AA-FE9F-40D3-9F2A-BE47E6F4F654

P2093

Q37703984-84949D08-2DE2-44BB-91FD-8BB98956E8B4

P2860

Q37703984-03CF5F05-806A-499A-9D0C-BA2FE011D7CD

Q37703984-0A510128-3414-48C3-ABCD-7262E9C0C1DB

Q37703984-0A5C1ABA-3A90-4B7E-A3E8-BCD70F367259

Q37703984-0CB09C09-55C3-4CCF-99C3-9C749EDF7944

Q37703984-0DA63F78-5877-40BD-A762-3937233024CD

Q37703984-123C0C02-1E90-4397-9CF6-69BC90E8DAA2

Q37703984-12F50C4F-5D1D-4693-B0FE-B7A83A7C4DB2

Q37703984-19134BA7-019C-4CA7-AE50-5B55925F894E

Q37703984-1CD8A0B2-F759-4D9E-844A-86B544D16013

Q37703984-217892AD-C233-475C-9464-F7243AB2E5FC

P304

Q37703984-FF5CF462-2811-44A1-8C24-B920F8AD87DA

P31

Q37703984-2EBB76CD-FB2A-4487-BAC2-B3E248AC8656

P356

Q37703984-A6D09606-01E1-4E63-A09A-9489D7505F11

P433

Q37703984-B015E730-0F46-439B-BBD1-B7D64F2ABCD1

P478

Q37703984-94ADB0CD-FCF6-4AD0-915C-E53EE0380E3C

P50

Q37703984-6CA0E9FC-4547-45C3-BFE2-B1E69AC9F013

Q37703984-DCC2DA37-DEC3-4305-BEDF-1E1E8BDB7854

P577

Q37703984-4822FB9E-DB6E-49EB-A507-FF4273AE0D82

P5875

Q37703984-495EE44F-94D9-4FB2-9AAA-1324F271F423

P698

Q37703984-9275B40A-48A0-4386-86C5-E6DCB4DABD2D

P921

Q37703984-60DEAEA1-F0A6-4ACA-BB99-CB8A70FE1581

P356

P1433

European Heart Journal

P1476

The current and future management of acute heart failure syndromes.

@en

P2093

Peter S Pang

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

Neurohumoral features of myocardial stunning due to sudden emotional stress

The failing heart--an engine out of fuel

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

P304

784-793

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHQ040

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Mihai Gheorghiade

P577

2010-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41808259

http://www.w3.org/2001/XMLSchema#string

P698

20207624

http://www.w3.org/2001/XMLSchema#string

P921